Etiology, Prevention and Treatment of Neonatal Infections in the Community

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine what are the major types of bacteria that cause newborn infections in the community in rural Bangladesh and whether providing an obstetric and neonatal care package will reduce neonatal deaths by 40%.

Detailed Description
-----------------
The study seeks answers to two questions: What are the major bacterial pathogens responsible for serious neonatal infections in the community in rural Bangladesh? Can provision of a package of obstetric and neonatal care, including active surveillance for serious neonatal illness and referral to hospital, and identification of barriers to care-seeking and design of strategies to address them reduce neonatal mortality rates by at least 40% compared to communities in which such services are not provided? Despite significant decline in infant and child mortality rates in recent decades, neonatal mortality rates remain unacceptably high. Of the 8 million infant deaths that occur worldwide each year, approximately 4 million occur in the neonatal period. Hence, the specific aims of the study include: identifying the principal agents of serious bacterial infections in Bangladeshi neonates in the community evaluating the impact of introducing a package of essential obstetric and neonatal care practices in the community, including identifying barriers to care-seeking and design of strategies to address those barriers and building capacity within Bangladesh by training Bangladeshi scientists in epidemiological and microbiological techniques, clinical research methods and best clinical practice through an on-going collaboration with Dhaka Shishu (Children) Hospital and the International Centre for Diarrhoeal Disease Research, Bangladesh.

Official Title
-----------------
Etiology, Prevention, and Treatment of Neonatal Infections in the Community

Conditions
-----------------
Bacterial Infection, Infectious Disease

Intervention / Treatment
-----------------
* Drug: Co-Trimoxazole; TMP-SMZ


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: pregnant women (any age) newborns Exclusion Criteria: children (outside newborn period)

Ages Eligible for Study
-----------------
Minimum Age: 1 Month

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Intervention/Treatment |
| --- |
|Drug: Co-Trimoxazole; TMP-SMZ|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Health workers will visit households at three month intervals for 18 months and survey the status of the babies. |  |  | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| At anytime during the study, if the baby shows symptoms of serious infection, the health worker will offer advice on where to go for treatment, or offer to treat the baby at home. |  |  | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Neonatal bacterial infection